Genomics

Dataset Information

Effective therapy of AML with RUNX1 mutation by co-treatment with inhibitors of protein translation and BCL2 [ATAC-seq]


ABSTRACT: Effective therapy of AML with RUNX1 mutation by co-treatment with inhibitors of protein translation and BCL2 [ATAC-seq]

PROVIDER: PRJNA754158 | ENA |

REPOSITORIES: ENA